preipo-investors-cash-in-on-mindray-before-lockup-expiry

Pre-IPO investors cash in on Mindray before lockup expiry

The $240 million sale is priced at a 2.5% discount and comes as the stock is up 86% since the September listing.
Existing shareholders have sold $240.8 million worth of Mindray Medical International shares through a fully marketed transaction that was priced after US markets closed on Tuesday January 30.

The sale, which came only four months after the company completed its initial public offering on the New York Stock Exchange, was priced at $24.50, which marked a discount of 2.5% to TuesdayÆs close of $25.12. Observers described this as ôquite tightö given that the share price had risen in each of the previous five trading days. Between the filing on January 17 and pricing, the stock fell 4.3% from a record high of $26.25, however.

Still, it was a sizeable sale in that it accounted...
¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222